{"id":"losartan-tablets","safety":{"commonSideEffects":[{"rate":"7-10","effect":"Dizziness"},{"rate":"3-5","effect":"Fatigue"},{"rate":"2-4","effect":"Hyperkalemia"},{"rate":"1-2","effect":"Cough"},{"rate":"5-7","effect":"Headache"},{"rate":"1-3","effect":"Hypotension"}]},"_chembl":null,"_dailymed":{"setId":"1bf520a2-a50e-a6ae-0fdf-9be4e69729c0","title":"LOSARTAN POTASSIUM TABLETS, 25 MG (LOSARTAN POTASSIUM) TABLET LOSARTAN POTASSIUM TABLETS, 50 MG (LOSARTAN POTASSIUM) TABLET LOSARTAN POTASSIUM TABLETS, 100 MG (LOSARTAN POTASSIUM) TABLET [JUBILANT CADISTA PHARMACEUTICALS INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Losartan is an angiotensin II receptor antagonist (ARB) that selectively blocks the AT1 receptor subtype. By preventing angiotensin II from binding to these receptors, it inhibits vasoconstriction and aldosterone secretion, leading to reduced peripheral vascular resistance and lower blood pressure. This mechanism also provides renal protection and reduces left ventricular hypertrophy.","oneSentence":"Losartan blocks angiotensin II receptors on blood vessels and tissues, causing vasodilation and reducing blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:53:14.182Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Diabetic nephropathy in patients with type 2 diabetes"},{"name":"Heart failure with reduced ejection fraction"}]},"trialDetails":[{"nctId":"NCT07300670","phase":"PHASE1","title":"The Effect of Losartan on Cephalexin","status":"RECRUITING","sponsor":"Aleksi Tornio","startDate":"2026-03-04","conditions":"Possible Interaction Between Losartan and Cephalexin, Healthy","enrollment":12},{"nctId":"NCT05012631","phase":"PHASE2","title":"Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2021-09-01","conditions":"Sickle Cell Disease, Diffuse Myocardial Fibrosis","enrollment":24},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT03900793","phase":"PHASE1","title":"Losartan + Sunitinib in Treatment of Osteosarcoma","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2019-08-26","conditions":"Osteosarcoma","enrollment":41},{"nctId":"NCT07135687","phase":"PHASE4","title":"Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-08","conditions":"ACL Injury, ACL Reconstruction, Scar Formation","enrollment":144},{"nctId":"NCT03563248","phase":"PHASE2","title":"Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2018-08-10","conditions":"Pancreatic Cancer","enrollment":168},{"nctId":"NCT07160361","phase":"PHASE4","title":"Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2025-10-01","conditions":"Carcinoma, Hepatocellular","enrollment":56},{"nctId":"NCT06796660","phase":"EARLY_PHASE1","title":"Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Liu Zhanghong","startDate":"2025-09-01","conditions":"Renal Insufficiency, Chronic","enrollment":70},{"nctId":"NCT06624904","phase":"EARLY_PHASE1","title":"Losartan and Social Processing","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-08-19","conditions":"Social Cognition","enrollment":68},{"nctId":"NCT07017023","phase":"EARLY_PHASE1","title":"Combined Blood Pressure Medication and Activity Scheduling for Low Mood","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-07-08","conditions":"Emotional Processing, Mood","enrollment":76},{"nctId":"NCT04715568","phase":"PHASE4","title":"Secondhand Tobacco Smoke and Cardiovascular Disease","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-03-30","conditions":"Cardiovascular Diseases, Hypertension","enrollment":100},{"nctId":"NCT04632589","phase":"EARLY_PHASE1","title":"Losartan for Improved Vascular Endothelial Function After Preeclampsia","status":"COMPLETED","sponsor":"Anna Stanhewicz, PhD","startDate":"2020-11-22","conditions":"Preeclampsia Postpartum","enrollment":11},{"nctId":"NCT06636812","phase":"EARLY_PHASE1","title":"Losartan and Emotional Processing in Young People","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-03-07","conditions":"Emotional Processing","enrollment":60},{"nctId":"NCT03946514","phase":"PHASE4","title":"Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-09-01","conditions":"Hypertension","enrollment":180},{"nctId":"NCT04927299","phase":"PHASE3","title":"Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2022-06-30","conditions":"Essential Arterial Hypertension","enrollment":163},{"nctId":"NCT05498675","phase":"","title":"Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2021-09-01","conditions":"Sacubitril/Valsartan, Hypertension, Obesity","enrollment":180},{"nctId":"NCT06628154","phase":"EARLY_PHASE1","title":"Losartan and Emotional Learning","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-08-14","conditions":"Emotional Processing","enrollment":60},{"nctId":"NCT03864042","phase":"PHASE1","title":"Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-01-02","conditions":"Advanced Solid Tumors, Metastatic Melanoma","enrollment":56},{"nctId":"NCT01149473","phase":"PHASE1","title":"Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2004-03","conditions":"Healthy","enrollment":80},{"nctId":"NCT01124175","phase":"PHASE1","title":"Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-10","conditions":"Healthy","enrollment":80},{"nctId":"NCT01277822","phase":"PHASE4","title":"Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-05-30","conditions":"Hypertension","enrollment":334},{"nctId":"NCT00447603","phase":"PHASE3","title":"A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-05-24","conditions":"Hypertension","enrollment":40},{"nctId":"NCT06431477","phase":"PHASE4","title":"Efficacy and Safety of Telmisartan Compared With Losartan","status":"RECRUITING","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2023-04-19","conditions":"Diabetic Nephropathies, Hypertension","enrollment":98},{"nctId":"NCT00568178","phase":"PHASE3","title":"An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-06-01","conditions":"Proteinuria","enrollment":306},{"nctId":"NCT01431508","phase":"PHASE4","title":"A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-08-01","conditions":"Hypertension","enrollment":15},{"nctId":"NCT01307046","phase":"PHASE3","title":"MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-03-29","conditions":"Hypertension","enrollment":336},{"nctId":"NCT01307033","phase":"PHASE3","title":"A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-03-29","conditions":"Hypertension","enrollment":278},{"nctId":"NCT00090259","phase":"PHASE3","title":"Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-12-19","conditions":"Heart Failure","enrollment":3834},{"nctId":"NCT06329076","phase":"NA","title":"Losartan Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT06329050","phase":"NA","title":"The Effects of Losartan on Attention Control: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT06108063","phase":"PHASE1, PHASE2","title":"Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan","status":"RECRUITING","sponsor":"Steadman Philippon Research Institute","startDate":"2024-03-06","conditions":"Knee Arthroplasty, Total","enrollment":120},{"nctId":"NCT00456963","phase":"PHASE4","title":"Prevention of Diabetes and Hypertension","status":"TERMINATED","sponsor":"Istituto Auxologico Italiano","startDate":"2007-09","conditions":"Diabetes Mellitus, Hypertension","enrollment":3000},{"nctId":"NCT03951142","phase":"PHASE2","title":"Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study","status":"UNKNOWN","sponsor":"Kyrre Eeg Emblem","startDate":"2019-10-01","conditions":"Glioblastoma, Brain Metastases","enrollment":165},{"nctId":"NCT05871333","phase":"PHASE2","title":"Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-07-17","conditions":"Chemotherapy, Colorectal Cancer, Intestinal Mucositis","enrollment":80},{"nctId":"NCT05827484","phase":"PHASE4","title":"The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries","status":"COMPLETED","sponsor":"Mostafa Hassanein, Msc","startDate":"2016-10-10","conditions":"PRP, Losartan, Muscle Injury","enrollment":20},{"nctId":"NCT05828940","phase":"NA","title":"Losartan and Memory","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-10-01","conditions":"PTSD","enrollment":41},{"nctId":"NCT01845688","phase":"NA","title":"Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy","status":"COMPLETED","sponsor":"wanglin","startDate":"2011-11","conditions":"Idiopathic Membranous Nephropathy","enrollment":72},{"nctId":"NCT05631782","phase":"EARLY_PHASE1","title":"Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients","status":"COMPLETED","sponsor":"The First People's Hospital of Zunyi","startDate":"2020-11-10","conditions":"Chronic Renal Failure, Hemodialysis","enrollment":160},{"nctId":"NCT03666351","phase":"PHASE4","title":"Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-10-18","conditions":"Aortic Stenosis, Aortic Regurgitation, Hypertension","enrollment":128},{"nctId":"NCT01620788","phase":"PHASE3","title":"Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment","status":"SUSPENDED","sponsor":"EMS","startDate":"2019-11-27","conditions":"Hypertension","enrollment":636},{"nctId":"NCT05462535","phase":"","title":"An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-02-26","conditions":"Hypertension,Essential","enrollment":4785},{"nctId":"NCT05450575","phase":"","title":"An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-04-17","conditions":"Hypertension, Dyslipidemia","enrollment":5400},{"nctId":"NCT04504045","phase":"PHASE1","title":"Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes","status":"TERMINATED","sponsor":"University of Southern Denmark","startDate":"2020-09-01","conditions":"Diabetes Mellitus, Type 2","enrollment":10},{"nctId":"NCT00953680","phase":"PHASE1","title":"Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-04","conditions":"Hypertension","enrollment":77},{"nctId":"NCT05212597","phase":"PHASE2","title":"Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2022-01-12","conditions":"Aortic Valve Insufficiency","enrollment":100},{"nctId":"NCT05090449","phase":"PHASE1","title":"Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting Conditions","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2019-05-01","conditions":"Healthy","enrollment":36},{"nctId":"NCT00720577","phase":"EARLY_PHASE1","title":"Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.","status":"COMPLETED","sponsor":"Medtronic Endovascular","startDate":"2005-12","conditions":"Peripheral Arterial Disease","enrollment":164},{"nctId":"NCT00879879","phase":"NA","title":"Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2009-03","conditions":"Precancerous Condition","enrollment":20},{"nctId":"NCT04428268","phase":"PHASE2","title":"Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia","status":"WITHDRAWN","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2020-03-10","conditions":"COVID-19 Pneumonia","enrollment":""},{"nctId":"NCT01852942","phase":"PHASE2","title":"Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2014-09","conditions":"HIV Infection, HIV Infections","enrollment":52},{"nctId":"NCT03206788","phase":"PHASE2","title":"Losartan and Inflammation in Cystic Fibrosis","status":"TERMINATED","sponsor":"University of Miami","startDate":"2017-11-11","conditions":"Cystic Fibrosis","enrollment":7},{"nctId":"NCT04606225","phase":"NA","title":"Losartan Effects on Emotion-memory Interaction","status":"UNKNOWN","sponsor":"University of Electronic Science and Technology of China","startDate":"2020-10-10","conditions":"Healthy","enrollment":60},{"nctId":"NCT04606212","phase":"NA","title":"The Effects of Losartan on Emotion Processing","status":"UNKNOWN","sponsor":"University of Electronic Science and Technology of China","startDate":"2020-10-10","conditions":"Healthy","enrollment":90},{"nctId":"NCT04604756","phase":"NA","title":"The Effects of Losartan on Social Reward","status":"UNKNOWN","sponsor":"University of Electronic Science and Technology of China","startDate":"2020-10-10","conditions":"Healthy","enrollment":90},{"nctId":"NCT02760615","phase":"PHASE4","title":"Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study","status":"WITHDRAWN","sponsor":"Takeda","startDate":"2016-11-01","conditions":"Colitis, Ulcerative, Crohn Disease","enrollment":""},{"nctId":"NCT04604938","phase":"NA","title":"The Effects of Losartan on Reward Reinforcement Learning","status":"UNKNOWN","sponsor":"University of Electronic Science and Technology of China","startDate":"2020-10-10","conditions":"Healthy","enrollment":60},{"nctId":"NCT01479439","phase":"PHASE2","title":"Losartan to Reverse Sickle Nephropathy","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2012-02","conditions":"Nephropathy, Sickle Cell Anemia","enrollment":36},{"nctId":"NCT03335904","phase":"PHASE4","title":"AT1R Blockade and Periodic Breathing During Sleep in Hypoxia","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2018-01-01","conditions":"Sleep Disordered Breathing, Hypoxia, Respiration; Sleep Disorder","enrollment":14},{"nctId":"NCT03978884","phase":"PHASE4","title":"Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes","status":"WITHDRAWN","sponsor":"The University of The West Indies","startDate":"2019-06-01","conditions":"Diabetes Mellitus, Hypertension","enrollment":""},{"nctId":"NCT04322266","phase":"PHASE1","title":"A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-12-21","conditions":"Healthy","enrollment":61},{"nctId":"NCT04222686","phase":"PHASE4","title":"Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients","status":"COMPLETED","sponsor":"Yaounde Central Hospital","startDate":"2017-12-20","conditions":"Type 2 Diabetes Mellitus","enrollment":23},{"nctId":"NCT04078711","phase":"PHASE2, PHASE3","title":"Chinese Medicine Treat for Hypertensive Renal Injury","status":"UNKNOWN","sponsor":"Jiangsu Province Hospital of Traditional Chinese Medicine","startDate":"2019-09-10","conditions":"Hypertension, Renal Injury","enrollment":520},{"nctId":"NCT02769130","phase":"PHASE1, PHASE2","title":"Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis","status":"SUSPENDED","sponsor":"The Hospital for Sick Children","startDate":"2016-05","conditions":"Pulmonary Vein Stenosis, Children","enrollment":40},{"nctId":"NCT02248961","phase":"PHASE3","title":"Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension","status":"COMPLETED","sponsor":"R-Pharm","startDate":"2014-05","conditions":"Arterial Hypertension","enrollment":179},{"nctId":"NCT02744456","phase":"EARLY_PHASE1","title":"N-of-1 Trials for Blood Pressure Medications in Adults","status":"COMPLETED","sponsor":"Columbia University","startDate":"2014-08-01","conditions":"Hypertension, High Blood Pressure","enrollment":10},{"nctId":"NCT01302691","phase":"PHASE3","title":"MK-0954E Study in Participants With Hypertension (MK-0954E-357)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-01-01","conditions":"Hypertension","enrollment":327},{"nctId":"NCT00981747","phase":"PHASE2, PHASE3","title":"Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis","status":"TERMINATED","sponsor":"Alicia Gerke","startDate":"2009-09","conditions":"Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis","enrollment":12},{"nctId":"NCT03459911","phase":"PHASE1","title":"A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions","status":"COMPLETED","sponsor":"Pharmtechnology LLC","startDate":"2018-02-16","conditions":"Healthy","enrollment":66},{"nctId":"NCT00675987","phase":"PHASE4","title":"A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2007-05","conditions":"Obesity, Hypertension, Hyperglycemia","enrollment":53},{"nctId":"NCT01292694","phase":"PHASE1","title":"Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure","status":"TERMINATED","sponsor":"Vanderbilt University","startDate":"2011-03","conditions":"Hypertension, Pure Autonomic Failure, Multiple System Atrophy","enrollment":12},{"nctId":"NCT03396523","phase":"NA","title":"Losartan and Emotion Processing","status":"UNKNOWN","sponsor":"University of Electronic Science and Technology of China","startDate":"2018-01-04","conditions":"Healthy","enrollment":70},{"nctId":"NCT00922480","phase":"PHASE3","title":"Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients","status":"COMPLETED","sponsor":"Boryung Pharmaceutical Co., Ltd","startDate":"2008-12","conditions":"Hypertension","enrollment":506},{"nctId":"NCT03434054","phase":"NA","title":"The Effect of Losartan on Emotional Processing in Healthy Volunteers","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2016-06-01","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT01216878","phase":"NA","title":"Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed Conditions","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2004-09","conditions":"Hypertension","enrollment":40},{"nctId":"NCT01102478","phase":"NA","title":"Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2005-02","conditions":"Hypertension","enrollment":30},{"nctId":"NCT01102465","phase":"NA","title":"Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2005-02","conditions":"Hypertension","enrollment":25},{"nctId":"NCT01216852","phase":"NA","title":"Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2004-08","conditions":"Hypertension","enrollment":40},{"nctId":"NCT03147092","phase":"EARLY_PHASE1","title":"Matão Controlling Hypertension (MatCH Study): Rationale and Design","status":"UNKNOWN","sponsor":"Centro Neurológico de Pesquisa e Reabiitação, Brazil","startDate":"2018-02-01","conditions":"Hypertension, Blood Pressure","enrollment":15000},{"nctId":"NCT01218022","phase":"PHASE1","title":"Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting Condition","status":"COMPLETED","sponsor":"Torrent Pharmaceuticals Limited","startDate":"","conditions":"Healthy","enrollment":""},{"nctId":"NCT01218698","phase":"PHASE1","title":"Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fed Condition","status":"COMPLETED","sponsor":"Torrent Pharmaceuticals Limited","startDate":"","conditions":"Healthy","enrollment":""},{"nctId":"NCT01218724","phase":"PHASE1","title":"Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fed Conditions","status":"COMPLETED","sponsor":"Torrent Pharmaceuticals Limited","startDate":"","conditions":"Healthy","enrollment":""},{"nctId":"NCT01218711","phase":"PHASE1","title":"Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.","status":"COMPLETED","sponsor":"Torrent Pharmaceuticals Limited","startDate":"","conditions":"Healthy","enrollment":""},{"nctId":"NCT03276598","phase":"PHASE4","title":"A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"1999-11-25","conditions":"Hypertension, Pharmacogenetics","enrollment":233},{"nctId":"NCT01648231","phase":"PHASE1","title":"Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-08-06","conditions":"Hypertension","enrollment":23},{"nctId":"NCT01797926","phase":"PHASE1","title":"Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-05-23","conditions":"Hypertension","enrollment":102},{"nctId":"NCT01913470","phase":"PHASE2","title":"Study of Losartan in the Treatment of NAFLD in Children","status":"COMPLETED","sponsor":"Miriam Vos, MD","startDate":"2013-07","conditions":"NAFLD","enrollment":12},{"nctId":"NCT00880386","phase":"NA","title":"Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer","status":"WITHDRAWN","sponsor":"University of South Florida","startDate":"2009-03","conditions":"Dyspnea, Lung Cancer, Pulmonary Complications","enrollment":""},{"nctId":"NCT02521246","phase":"PHASE3","title":"Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control","status":"WITHDRAWN","sponsor":"EMS","startDate":"2016-11","conditions":"Essential Arterial Hypertension","enrollment":""},{"nctId":"NCT02521233","phase":"PHASE3","title":"Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control","status":"WITHDRAWN","sponsor":"EMS","startDate":"2016-11","conditions":"Essential Arterial Hypertension","enrollment":""},{"nctId":"NCT02231125","phase":"PHASE4","title":"Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy","status":"UNKNOWN","sponsor":"Chen Xiangmei","startDate":"2014-09","conditions":"IgA Nephropathy","enrollment":1600},{"nctId":"NCT00856960","phase":"PHASE1","title":"The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-01","conditions":"Hypertension","enrollment":12},{"nctId":"NCT02010905","phase":"PHASE2","title":"Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System","status":"UNKNOWN","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2013-12","conditions":"Tetralogy of Fallot, Heart Defects, Congenital, Ventricular Dysfunction, Right","enrollment":120},{"nctId":"NCT00882440","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"1990-12","conditions":"Hypertension","enrollment":576},{"nctId":"NCT02504606","phase":"PHASE1","title":"Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject","status":"COMPLETED","sponsor":"Huons Co., Ltd.","startDate":"2014-09","conditions":"Hypertension","enrollment":60},{"nctId":"NCT02063100","phase":"PHASE4","title":"Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis","status":"UNKNOWN","sponsor":"Chinese PLA General Hospital","startDate":"2014-02","conditions":"Glomerulonephritis, Proteinuria","enrollment":720},{"nctId":"NCT02212769","phase":"PHASE1","title":"the Pharmacokinetic Profiles of Losartan With DW1029M","status":"COMPLETED","sponsor":"Dong Wha Pharmaceutical Co. Ltd.","startDate":"2014-08","conditions":"Healthy","enrollment":12},{"nctId":"NCT02166398","phase":"PHASE1","title":"A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Korea United Pharm. Inc.","startDate":"2014-06","conditions":"Healthy","enrollment":46},{"nctId":"NCT02446548","phase":"NA","title":"Influence of Aliskiren on Albuminuria After Kidney Transplantation","status":"COMPLETED","sponsor":"Medical University of Gdansk","startDate":"2013-03","conditions":"Albuminuria","enrollment":18},{"nctId":"NCT01675362","phase":"PHASE4","title":"Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2012-08","conditions":"Kidney Calculi","enrollment":160},{"nctId":"NCT01176032","phase":"PHASE4","title":"ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2010-06","conditions":"Hypertension, Left Ventricle Hypertrophy","enrollment":74}],"_emaApprovals":[],"_faersSignals":[{"count":11,"reaction":"DRUG INEFFECTIVE"},{"count":9,"reaction":"PRODUCT SUBSTITUTION ISSUE"},{"count":8,"reaction":"HYPERTENSION"},{"count":7,"reaction":"DYSPNOEA"},{"count":6,"reaction":"ASTHENIA"},{"count":5,"reaction":"ABDOMINAL DISCOMFORT"},{"count":5,"reaction":"ACUTE KIDNEY INJURY"},{"count":5,"reaction":"COUGH"},{"count":5,"reaction":"DIZZINESS"},{"count":5,"reaction":"HEADACHE"}],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Losartan Tablets","genericName":"Losartan Tablets","companyName":"Istituto Auxologico Italiano","companyId":"istituto-auxologico-italiano","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Losartan blocks angiotensin II receptors on blood vessels and tissues, causing vasodilation and reducing blood pressure. Used for Hypertension, Diabetic nephropathy in patients with type 2 diabetes, Heart failure with reduced ejection fraction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}